1Grundy SM, Cleeman Ji, Meii CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines. Circulation, 2004, 110 ( 2 ) :227-239.
2Gotto AM Jr, Brinton EA. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol, 2004, 43(5) :717-724.
10Tarlor AJ, Sullenberger LE, Lee HJ, et al. Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2: a double-blind ,placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulaton, 2004, 110(23) :3512-3517.
